Blood Glucose Monitoring Devices Market Size and Share Forecast Outlook 2025 to 2035
The Blood Glucose Monitoring Devices Market is estimated to be valued at USD 14.9 billion in 2025 and is projected to reach USD 22.9 billion by 2035, registering a compound annual growth rate (CAGR) of 4.4% over the forecast period.
Quick Stats for Blood Glucose Monitoring Devices Market
- Blood Glucose Monitoring Devices Market Industry Value (2025): USD 14.9 billion
- Blood Glucose Monitoring Devices Market Forecast Value (2035): USD 22.9 billion
- Blood Glucose Monitoring Devices Market Forecast CAGR: 4.4%
- Leading Segment in Blood Glucose Monitoring Devices Market in 2025: Self-Monitoring Device (61.3%)
- Key Growth Region in Blood Glucose Monitoring Devices Market: North America, Asia-Pacific, Europe
- Top Key Players in Blood Glucose Monitoring Devices Market: Abbott Laboratories, ARKRAY, Inc., Bayer AG; Medtronic plc, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Ascensia Diabetes Care, Nipro Diagnostics, Inc., Dexcom, Inc., Sanofi, Terumo Medical Corporation, Novo Nordisk, Ypsomed Holdings, Prodigy Diabetes Care, LLC, GlySens Incorporated, ACON Laboratories, Nova Biomedical, Medtronic, Dexcom, Inc., LifeScan IP Holdings, LLC, Senseonics
| Metric |
Value |
| Blood Glucose Monitoring Devices Market Estimated Value in (2025 E) |
USD 14.9 billion |
| Blood Glucose Monitoring Devices Market Forecast Value in (2035 F) |
USD 22.9 billion |
| Forecast CAGR (2025 to 2035) |
4.4% |
Rationale for Segmental Growth in the Blood Glucose Monitoring Devices Market
The blood glucose monitoring devices market is expanding steadily as the prevalence of diabetes continues to rise globally. Growth is being driven by increasing awareness of diabetes management, expanding patient education programs, and improvements in device technology that support accuracy and convenience.
The current scenario reflects strong adoption of both self-monitoring and continuous monitoring systems, supported by healthcare initiatives encouraging regular blood glucose tracking. Regulatory approvals and reimbursement frameworks are enhancing access, while the entry of advanced digital health platforms is fostering integration with mobile and cloud-based ecosystems.
The future outlook is defined by innovation in minimally invasive and non-invasive modalities, alongside the growing demand for portable devices that offer real-time insights and patient autonomy Growth rationale is supported by the necessity of ongoing monitoring in chronic disease management, rising healthcare expenditures, and the ability of manufacturers to deliver compact, user-friendly, and connected devices, which collectively position the market for sustained expansion and broader adoption across both developed and emerging regions.
Segmental Analysis
Insights into the Product Segment
The self-monitoring device segment, accounting for 61.30% of the product category, has maintained its lead due to its affordability, accessibility, and ease of use. Adoption has been driven by its ability to provide quick results that support daily diabetes management. The segment benefits from widespread distribution through pharmacies and retail channels, ensuring availability for both urban and rural populations.
Technological improvements in test strips, lancets, and compact meters have enhanced accuracy and user confidence. Cost-effectiveness compared to continuous monitoring systems has reinforced market preference, particularly in developing economies where affordability plays a critical role.
Integration with digital platforms and mobile applications has further improved patient compliance and engagement These advantages have solidified the position of self-monitoring devices as the dominant product type in the blood glucose monitoring devices market.
Insights into the Usage Segment
The invasive segment, representing 72.10% of the usage category, continues to dominate due to its long-standing presence and clinical reliability. Its market share has been sustained by consistent demand for conventional testing methods, which remain widely prescribed by healthcare providers.
Invasive devices are supported by established reimbursement systems and regulatory approvals, ensuring continued trust among patients and clinicians. Technological refinements have minimized discomfort and improved ease of sampling, enhancing patient adherence to testing protocols.
Cost advantages compared to emerging non-invasive alternatives have reinforced adoption across a broad patient base While innovation in non-invasive technologies is progressing, invasive devices are expected to remain the primary choice in the near term due to their proven accuracy, affordability, and widespread clinical acceptance.
Insights into the Modality Segment
The portable segment, holding 54.60% of the modality category, has been leading the market due to rising demand for compact and user-friendly devices that support on-the-go monitoring. Its growth is supported by increasing lifestyle-related diabetes cases and the need for continuous monitoring outside clinical settings.
Advances in portability, combined with Bluetooth connectivity and integration with health apps, have strengthened user engagement and compliance. Distribution through retail, hospital, and e-commerce channels has expanded access, driving adoption across diverse demographics.
Cost competitiveness compared to wearable continuous monitors has made portable devices a practical solution for daily glucose management Ongoing innovation in miniaturization, accuracy, and connectivity is expected to sustain the segment’s dominance, ensuring portable devices remain a cornerstone of the blood glucose monitoring devices market.
Sales Trend Analysis from 2020 to 2025 Compared to Market Outlook for 2025 to 2035
- Blood glucose monitoring equipment will continue to be in high demand, least affected by any industry margin compressions. The preference for these devices is growing for monitoring the blood glucose level. This is a major factor in increasing the production of blood glucose monitoring devices.
- A wide number of healthcare facilities utilize continuous blood glucose monitoring devices (CGMs), to reduce the frequency of POCT testing associated with blood glucose monitoring.
Top Blood Glucose Monitoring Devices Market Dynamics and Industry Trends
| CAGR from 2020 to 2025 |
5.0% |
| CAGR from 2025 to 2035 |
4.9% |
- The COVID-19 outbreak has necessitated the use of continuous blood glucose monitoring devices (CGMs) to reduce the amount of nursing exposure to COVID-19 patients with diabetes.
- The time needed to obtain blood glucose measurements, and the amount of personal protective equipment needed for interacting with patients during the blood glucose testing can all be reduced by using continuous blood glucose monitoring devices to replace assisted monitoring of blood glucose by bedside nurses.
- The use of telemedicine during the COVID-19 lockdown for diabetes management increased the use of blood glucose monitoring devices thus propelling the market growth.
- Growing number of diabetic patients might be attributed in part to the global population's dietary habits and lifestyle patterns. Increased consumption of junk food, alcohol and a sedentary lifestyle all contribute to the rise in diabetes cases.
Lucrative Opportunities Driving Demand Growth in the Blood Glucose Monitoring Devices Market
- The demand for blood glucose monitoring devices is being boosted by the significant expansion in the diabetic population and ongoing technological improvements in blood glucose monitoring devices.
- Before, type 2 diabetes was only found in adults, but it is becoming increasingly common in kids as well. Monitoring blood glucose levels is becoming more and more important with its increasing prevalence in children.
- The rising prevalence of gestational diabetes in women. Complications during pregnancy and delivery are more likely in women with gestational diabetes. Hence, these factors are opening opportunities for the growth of the blood glucose monitoring devices market.
Factors Restraining the Demand for Blood Glucose Monitoring Devices
- The fact that a significant portion of the population has undiagnosed diabetes is one of the major reasons blood glucose monitoring systems are not used as frequently as they should be, particularly in emerging economies.
- The chronic disorders such as diabetes mellitus are not well-known to the general population. Expansion may also be hampered by the absence of standard operating procedures by public or commercial entities as well as by limited access to advanced healthcare infrastructure.
Analysis of Top Countries Prescribing,Distributing,Monitoring,and Adopting Blood Glucose Monitoring Devices
| Countries |
2035 Value CAGR in Global Market |
| United States |
3.9% |
| United Kingdom |
3.8% |
| China |
4.8% |
| Germany |
4.1% |
Blood Glucose Monitoring Device Market in China
- The market will rise as a result of increased product accessibility, more consumer awareness, and business expansion by industry participants across the nation.
- Government programmes and efforts to raise awareness of diabetes management will spur business growth. For instance, the "National diabetes programme" (WDF02-036) initiative in China, which is supported by the World diabetes foundation (WDF), is focused on those who have diabetes by emphasising treatment and capacity building across the country's healthcare system.
Blood Glucose Monitoring Devices Market in the United States
- Rising cases of obesity are one of the main causes of type 2 diabetes in the population of the USA According to the Centres for Disease Control and Prevention, the obesity prevalence rate in the United States from 2020 to March 2024 was 41.7%.
- According to an estimate provided by the CDC in 2024, 14.3 million new cases of diabetes were diagnosed in the USA This is a prime driver for the production of blood glucose monitoring devices within the country.
Blood Glucose Monitoring Devices Market in Germany
- The market is driven by the strict regulation of the price and reimbursement policies. For instance, Germany's Federal Joint Committee provided Dexcom with reimbursement for its continuous glucose monitoring system for patients with insulin-dependent type 1 and type 2 diabetes.
- The companies in the diabetes care device market, some of the potential opportunities include the introduction of numerous new products and an increase in international research collaborations for technological advancement.
Blood Glucose Monitoring Devices Market in the United Kingdom
- Increasing awareness of blood glucose management in individuals is expected to drive the market in the region. Furthermore, a growing understanding of the link between blood glucose levels and chronic diseases is expected to create significant opportunities for the market in the forecast period.
Blood Glucose Monitoring Devices Industry Analysis by Top Investment Segments
| Attributes |
Details |
| By Product Type |
Self-Monitoring Devices |
| Market Share in 2025 |
71.4% |
- Self-monitoring devices are expected to present a growth at a CAGR rate of 4.5% by the end of the forecast period, with a market share of about 71.4% in the global market in 2025.
- Self-monitoring has simplified the process of using routine blood tests to evaluate diabetes control and notify of changes to improve control.
- Technology-enhanced self-monitoring is considered safe and effective at producing positive health results.
| Attributes |
Details |
| By Distribution Channel |
Retail Pharmacy |
| Market Share in 2025 |
38.2% |
- Retail pharmacies hold the greatest portion of the distribution channel segment with a market share of 38.2% in 2025, owing to the fact that retail pharmacies offer a variety of options for blood glucose monitoring devices.
- The retail pharmacies are easily accessible and hence preferred by consumers for the purchase of blood glucose monitoring devices.
Leading Suppliers of Blood Glucose Monitoring Devices
To meet consumer demand and expand their customer base, major players are concentrating on new product launches, regulatory approvals, acquisitions, improvements in current products & technologies, and other methods to increase their business portfolio & fortify their presence.
Recent developments
- In June 2025, Abbott announced the development of new bio-wearable to monitor ketone and glucose levels continuously in one sensor. The system has received the USA FDA breakthrough device designation.
- In November 2024, Intuity Medical announced the launch of the POGO Automatic Blood Glucose Monitoring System which is the first blood glucose monitor that performs automatic testing. This device automatically lances and collects blood to check the blood glucose level.
Similarly, recent developments related to companies manufacturing blood glucose monitoring device products have been tracked by the team at Future Market Insights, which are available in the full report.
Top Segments Studied in the Blood Glucose Monitoring Devices Market Report
By Product:
- Self-monitoring device
- Continuous blood glucose monitoring devices
By Usage:
By Modality:
By Indication:
- Type 1
- Type 2
- Gestational Diabetes
By Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- Diagnostic Centres
- Online Sales
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan (APEJ)
- Japan
- Middle East & Africa
Frequently Asked Questions
How big is the blood glucose monitoring devices market in 2025?
The global blood glucose monitoring devices market is estimated to be valued at USD 14.9 billion in 2025.
What will be the size of blood glucose monitoring devices market in 2035?
The market size for the blood glucose monitoring devices market is projected to reach USD 22.9 billion by 2035.
How much will be the blood glucose monitoring devices market growth between 2025 and 2035?
The blood glucose monitoring devices market is expected to grow at a 4.4% CAGR between 2025 and 2035.
What are the key product types in the blood glucose monitoring devices market?
The key product types in blood glucose monitoring devices market are self-monitoring device and continuous blood glucose monitoring devices.
Which usage segment to contribute significant share in the blood glucose monitoring devices market in 2025?
In terms of usage, invasive segment to command 72.1% share in the blood glucose monitoring devices market in 2025.
